Schwabe: Intraocular Pressure Analyzer

2021: Intraocular pressure analyzer announcement to detect initial glaucoma stage

In December 2021, the Schwabe holding presented an ophthalmic analyzer of intraocular pressure to identify the initial stage of glaucoma. The device was developed by the Zagorsk Optical and Mechanical Plant (ZOMZ; included in Schwab) together with the Research Institute of Eye Diseases.

The device performs intraocular pressure (IOP) measurements for a period of 10 to 20 seconds using pneumotonometry with continuous air flow. On the basis of the obtained measurement data, the built-in computer of the analyzer builds a diagram showing HPG fluctuations caused by pulsating blood flow entering and leaving the eye.

Schwabe introduced an intraocular pressure analyzer to detect the initial stage of glaucoma

The device analyzes the diagram and determines the volume of blood flow. In practice, this means that the analyzer can detect both the predisposition to glaucoma and the disease itself in the early stages, when treatment is most effective.

According to the press service of Rostec (this state corporation includes the Schwabe holding), the initial glaucoma often develops without obvious symptoms, and to identify it, doctors need special devices. The initial stage of glaucoma is when paracentral scotomas are determined, there is an expansion of the optical disk, excavation of the optic nerve disk does not reach its edge.

The press release cites the words of the interim general director of ZOMZ Konstantin Pertsev, who noted that, according to statistics, in 30-40% of cases the initial glaucoma is not diagnosed. It develops asymptomatically with normal, average, ocular pressure.

Using an analyzer, errors during the survey can be avoided, "said Pertsev.

The start of mass production of an ophthalmic intraocular pressure analyzer is scheduled for 2022.^[1]

Notes